Amkor Q1 Earnings Preview: High Valuation Faces Test, CPU Mass Production Becomes Key

Fourth-quarter 2025 revenue was $1.888 billion, up 16% year-over-year, while net income reached $172 million; earnings per share of $0.69 beat market expectations of $0.44 by $0.25, and gross margin hit 16.7%, up 240 basis points year-over-year.

Full-year 2025 revenue totaled $6.708 billion, a 6% increase year-over-year. Net income was $374 million, with earnings per share at $1.50. Gross margin stood at 14%, while operating cash flow reached $1.1 billion and free cash flow was approximately $308 million.

Notably, the stock has risen by a cumulative 60% following the fourth-quarter earnings beat, and the current P/E ratio already fully reflects the market's optimistic growth expectations for 2026.

Short-term catalysts are primarily driven by the pace of CPU mass production. The 2.5D integration and high-density fan-out packaging platforms are the main growth engines; the company expects combined growth for these two segments to nearly triple by 2026, with overall growth in the computing business exceeding 20%.

Two CPU high-density fan-out projects are currently in the final validation stage, with mass production slated for the second half of 2026. If production proceeds smoothly, it could boost annual revenue growth by approximately 8% to 10% in an optimistic scenario. If delayed until 2027, the annual growth rate would drop below 5%.

Potential causes for delays include extended lead times for upstream temporary bonding equipment, the postponement of next-generation CPU platform launches by Intel and AMD to 2027, and supply chain constraints facing Amkor itself, such as R&D staffing shortages and export controls.

In terms of capacity footprint, Amkor has 20 production sites across eight countries. The Vietnam facility is the world's largest single OSAT plant, with cumulative investments totaling $1.6 billion, while the Arizona facility currently under construction will be the largest outsourced packaging plant in North America.

The Vietnam plant has reached the break-even point, and revenue is expected to double this year. Cleanroom capacity in South Korea will increase by 20% by year-end, and equipment expenditures are also expected to rise by approximately 40% year-over-year.

The Arizona facility has faced significant long-term capital expenditure pressure. With a total investment of approximately $7 billion, construction is expected to conclude by mid-2027, with production starting in early 2028 at an initial capacity of 25,000 wafers per month. The facility may receive $2.8 billion in government support as well as additional CHIPS Act funding.

CapEx guidance for 2026 is set between $2.5 billion and $3 billion, roughly 8 to 10 times the free cash flow for 2025. Two-thirds of this capital will be used for facility expansions in Arizona, South Korea, and Taiwan. A UBS report from January noted that Phase 1 of the Arizona project will generate roughly $1 billion in negative free cash flow from Q4 2025 through 2028.

It is also worth noting that the company's gross margin guidance for the first quarter is between 12.5% and 13.5%, down from 16.7% in the fourth quarter of 2025.

Investors should focus on the mass production progress of CPU projects in the second half of the year, whether gross margins can return to above 15%, and the actual impact of capital expenditure on free cash flow.

Furthermore, the market generally considers the company to have high customer concentration, with 30% to 40% of Amkor's revenue derived from Apple; if iPhone shipments decline, Amkor's communications revenue is expected to decrease.

Sales in the Chinese market account for approximately 6% of total 2026 sales. If U.S. export controls on GPUs become more stringent, this portion of revenue could decrease significantly or even be eliminated.

Amkor holds a strategic technological position in AI advanced packaging, but its stock price has already priced in high growth expectations. If the quarterly report does not provide H2 guidance that exceeds expectations, the valuation may see a correction.

[Source: TradingKey]

The consensus rating among 12 analysts is "Hold," with an average price target of $54.68, representing a 22.12% downside from the current price of approximately $78. Needham and JPMorgan have set price targets of $65. On April 17, Melius Research upgraded the rating to "Buy" and issued a $60 price target. UBS downgraded the stock from Buy to Neutral in January, noting that the roughly 250% rally from the April 2025 low already fully reflects growth expectations. B. Riley maintains a Neutral rating, while Goldman Sachs has a price target of $43.

This content was translated using AI and reviewed for clarity. It is for informational purposes only.